Jiatong Xiao

Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Tro-score, a trogocytosis-related transcriptomic signature, identifies CD109 as a therapeutic target for reversing immunosuppression in bladder cancer.

Tro-score, a trogocytosis-related transcriptomic signature, identifies CD109 as a therapeutic target for reversing immunosuppression in bladder cancer.

Journal: International immunopharmacology

Published: June 20, 2026

Erratum to "Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer".

Erratum to "Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer".

Journal: Biomaterials research

Published: November 17, 2025

The ZNF737-CXCL10 axis drives immune exclusion and resistance to anti-PD-1 therapy in bladder cancer.

The ZNF737-CXCL10 axis drives immune exclusion and resistance to anti-PD-1 therapy in bladder cancer.

Journal: International immunopharmacology

Published: September 20, 2025

Nuclear receptors meet natural sesquiterpenes: From preclinical mechanisms to therapeutic potential.

Nuclear receptors meet natural sesquiterpenes: From preclinical mechanisms to therapeutic potential.

Journal: European journal of pharmacology

Published: August 27, 2025

Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review.

Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review.

Journal: Cancer immunology, immunotherapy : CII

Published: August 03, 2025

Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.

Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.

Journal: Journal for immunotherapy of cancer

Published: July 16, 2025

Pan-cancer analysis of the impact of fatty acids: a two-sample and multivariable Mendelian randomization study.

Pan-cancer analysis of the impact of fatty acids: a two-sample and multivariable Mendelian randomization study.

Journal: Discover oncology

Published: February 05, 2025

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study.

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study.

Journal: iMeta

Published: January 29, 2025

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer.

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer.

Journal: Journal of hematology & oncology

Published: September 27, 2024

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance.

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance.

Journal: Theranostics

Published: September 03, 2024

Evaluating male sexual function and reproductive health during Omicron outbreak in China.

Evaluating male sexual function and reproductive health during Omicron outbreak in China.

Journal: PloS one

Published: March 20, 2024

Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling.

Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling.

Journal: Cellular & molecular biology letters

Published: March 15, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026